ELANTAS13,370.00

Elantas Beck India Limited

· Chemicals
₹ CrorePeersAMALARCLCHEMCRUXDAICHIGRAUWEILINDOKEMJYOTIRESKANCHI
Comp Set
In ₹ Crore except Per Share
Latest Annual
ELANTAS
FY25
AMAL
FY26
ARCL
FY25
CHEMCRUX
FY26
Peer
Median
Valuation — at last close
P/E71.72×26.06×16.20×21.13× +239%
Growth
Revenue CAGR 3Y29.43%-4.61%12.41%
Revenue CAGR 5Y22.79%22.79%
Net Income CAGR 3Y83.96%-68.48%7.74%
Profitability
EBITDA Margin20.31%9.59%9.48%12.38%9.59% +112%
Net Income Margin17.43%5.35%4.69%0.54%4.69% +272%
Return on Common Equity14.66%4.56%15.53%10.04% +46%
Return on Capital Employed14.45%6.28%18.49%12.38% +17%
Return on Assets12.67%3.88%7.30%2.54%3.88% +227%
Credit & Quality
Total Debt/Equity0.46×0.46×
Interest Coverage293.96×10.06×3.81×6.01×6.01× +4791%
Scale — latest FY
Revenue / Total Income₹848 Cr₹84.9 Cr₹251 Cr₹82.6 Cr₹84.9 Cr +898%
Net Income₹148 Cr₹4.5 Cr₹11.8 Cr₹0.4 Cr₹4.5 Cr +3156%
Total Assets₹1,166 Cr₹117 Cr₹161 Cr₹17.7 Cr₹117 Cr +897%
EPS₹186.41₹28.9₹14.69₹21.79 +755%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.